CLINICAL NEWS

Post-PCI bleeding reduced with changes in strategy

Changes in procedural antithrombotic strategy are associated with a significant temporal reduction in major bleeding over time in patients undergoing elective post-percutaneous intervention, according to a study published in the Journal of the American College of Cardiology. » More

CONTINUING EDUCATION

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

EDITOR’S PICK

Apixaban: Factor Xa inhibitor to prevent strokes and systemic embolism

Apixaban (Eliquis) is an orally active factor Xa inhibitor. Its manufacturers are seeking FDA approval to market apixaban to reduce risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. » Click here.

CLINICAL NEWS

Many diabetes patients don’t receive recommended first-line drug

More than a third of patients newly diagnosed with type 2 diabetes mellitus did not receive the recommended first-line drug, a finding that could have substantial implications for healthcare spending, according to a study published in the American Journal of Medicine. » More

Statin therapy may benefit low-risk patients

Statin therapy is safe and effective for people at low risk of major vascular events and, therefore, current guidelines might need to be reconsidered, according to a study published online in The Lancet. » More

Folic acid supplementation may lower risk of certain childhood cancers

Folic acid fortification of US grain products may be lowering rates of certain kidney and brain cancers in children but does not appear to be causing childhood cancer rates to increase, according to findings from a study published online May 22 in the journal Pediatrics. » More

TECHNOLOGY

Study: Increase in e-prescribing helps adherence, costs

The number of physicians and clinicians using e-prescribing increased by 67% in 2011 and they filled 75% more medication orders electronically, according to a new downloadable report by Surescripts, which operates a nationwide network connecting the computer systems of physicians and pharmacies. » More

Survey

Based upon your experience with Medication Therapy Management (MTM) programs and services to date, how would you assess their impact in improving healthcare quality and lowering healthcare costs in their targeted patient population?

a) Highly effective
b) Somewhat effective
c) Neutral
d) Somewhat ineffective
e) Largely ineffective

Click here and see what your colleagues think, too.

Want to see the results of our last survey about specialty pharmacy services? Click here.

Like us on Facebook

Resources

•	Drug Watch
•	FDA Actions
•	Latest News
•	Medication Safety
•	Policy Watch

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.